TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression

The TGFβ pathway is under active consideration as a cancer drug target based on its capacity to promote cancer cell invasion and to create a pro-tumorigenic microenvironment. However, the clinical application of TGFβ inhibitors remains uncertain as genetic studies demonstrate a tumor suppressor func...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hezel, Aram F., Deshpande, Vikram, Zimmerman, Stephanie M., Contino, Gianmarco, Alagesan, Brinda, O’Dell, Michael R., Rivera, Lee B., Harper, Jay, Lonning, Scott, Brekken, Rolf A., Bardeesy, Nabeel
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764481/
https://ncbi.nlm.nih.gov/pubmed/22787119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-0634
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki